One step closer to a CMV vaccine

New England Journal of Medicine

Volumn 360, Issue 12, 2009, Pages 1250-1252

  Dekker, Cornelia L ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GLYCOPROTEIN B; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;

CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; MATERNAL TREATMENT; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS TRANSMISSION; CYTOMEGALOVIRUS; FEMALE; NOTE; PREGNANCY COMPLICATION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 62749195515     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0900230     Document Type: Editorial

References (12)

1. Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009;360:1191-9.
2. Weller TH, Hanshaw JB, Scott DE. Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology 1960;12:130-2.
3. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-63.
4. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-76.
5. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7.
6. Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health 2006;15:224-9.
7. Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7:71.
8. Murph JR, Souza IE, Dawson JD, et al. Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol 1998;147:940-7.
9. Pass RF, Hutto C, Ricks R, Cloud GA. Increased rate of cytomegalovirus infection among parents of children attending day care centers. N Engl J Med 1986;314:1414-8.
10. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995;171:1115-21.
11. Adler SP. Human CMV vaccine trials: what if CMV caused a rash? J Clin Virol 2008;41:231-6.
12. Novak Z, Ross SA, Patro RK, et al. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 2008;46:882-6.